These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 27693579)

  • 1. The oxoglutarate receptor 1 (OXGR1) modulates pressure overload-induced cardiac hypertrophy in mice.
    Omede A; Zi M; Prehar S; Maqsood A; Stafford N; Mamas M; Cartwright E; Oceandy D
    Biochem Biophys Res Commun; 2016 Oct; 479(4):708-714. PubMed ID: 27693579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TNIP3 protects against pathological cardiac hypertrophy by stabilizing STAT1.
    Shi H; Yu Y; Li D; Zhu K; Cheng X; Ma T; Tao Z; Hong Y; Liu Z; Zhou S; Zhang J; Chen Y; Zhang XJ; Zhang P; Li H
    Cell Death Dis; 2024 Jun; 15(6):450. PubMed ID: 38926347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FBXW5 acts as a negative regulator of pathological cardiac hypertrophy by decreasing the TAK1 signaling to pro-hypertrophic members of the MAPK signaling pathway.
    Hui X; Hu F; Liu J; Li C; Yang Y; Shu S; Liu P; Wang F; Li S
    J Mol Cell Cardiol; 2021 Feb; 151():31-43. PubMed ID: 32971071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SNX5-Rab11a protects against cardiac hypertrophy through regulating LRP6 membrane translocation.
    Li Y; Wang X; Bi Y; Zhang M; Xiong W; Hu X; Zhang Y; He F
    J Mol Cell Cardiol; 2024 Sep; 194():46-58. PubMed ID: 38950816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leucine zipper protein 1 attenuates pressure overload-induced cardiac hypertrophy through inhibiting Stat3 signaling.
    Fan D; Jiang WL; Jin ZL; Cao JL; Li Y; He T; Zhang W; Peng L; Liu HX; Wu XY; Chen M; Fan YZ; He B; Yu WX; Wang HR; Hu XR; Lu ZB
    J Adv Res; 2024 Sep; 63():117-128. PubMed ID: 37806546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of 2-oxoglutarate receptor 1 (OXGR1) by α-ketoglutarate (αKG) does not detectably stimulate Pendrin-mediated anion exchange in Xenopus oocytes.
    Heneghan JF; Majmundar AJ; Rivera A; Wohlgemuth JG; Dlott JS; Snyder LM; Hildebrandt F; Alper SL
    Physiol Rep; 2022 Jul; 10(14):e15362. PubMed ID: 35851763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mice lacking functional TRPV1 are protected from pressure overload cardiac hypertrophy.
    Buckley CL; Stokes AJ
    Channels (Austin); 2011; 5(4):367-74. PubMed ID: 21814047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role Played by Transcription Factor E3 in Modulating Cardiac Hypertrophy.
    Rishiq A; Islam O; Golomb E; Gilon D; Smith Y; Savchenko I; Eliaz R; Foo RS; Razin E; Tshori S
    Int Heart J; 2021 Nov; 62(6):1358-1368. PubMed ID: 34744144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The m7G Methyltransferase Mettl1 Drives Cardiac Hypertrophy by Regulating SRSF9-Mediated Splicing of NFATc4.
    Yu S; Sun Z; Ju T; Liu Y; Mei Z; Wang C; Qu Z; Li N; Wu F; Liu K; Lu M; Huang M; Pang X; Jia Y; Li Y; Zhang Y; Dou S; Jiang J; Dong X; Huang C; Li W; Zhang Y; Yuan Y; Yang B; Du W
    Adv Sci (Weinh); 2024 Aug; 11(29):e2308769. PubMed ID: 38810124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-mediated neutralization of IL11 signalling reduces ERK activation and cardiac fibrosis in a mouse model of severe pressure overload.
    Lim WW; Corden B; Ye L; Viswanathan S; Widjaja AA; Xie C; Su L; Tee NGZ; Schafer S; Cook SA
    Clin Exp Pharmacol Physiol; 2021 Apr; 48(4):605-613. PubMed ID: 33462828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OXGR1 is a candidate disease gene for human calcium oxalate nephrolithiasis.
    Majmundar AJ; Widmeier E; Heneghan JF; Daga A; Wu CW; Buerger F; Hugo H; Ullah I; Amar A; Ottlewski I; Braun DA; Jobst-Schwan T; Lawson JA; Zahoor MY; Rodig NM; Tasic V; Nelson CP; Khaliq S; Schönauer R; Halbritter J; Sayer JA; Fathy HM; Baum MA; Shril S; Mane S; Alper SL; Hildebrandt F
    Genet Med; 2023 Mar; 25(3):100351. PubMed ID: 36571463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-320 accelerates chronic heart failure with cardiac fibrosis through activation of the IL6/STAT3 axis.
    Li F; Li SS; Chen H; Zhao JZ; Hao J; Liu JM; Zu XG; Cui W
    Aging (Albany NY); 2021 Sep; 13(18):22516-22527. PubMed ID: 34582362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated Quantitative Phosphoproteomics and Cell-based Functional Screening Reveals Specific Pathological Cardiac Hypertrophy-related Phosphorylation Sites.
    Kwon HK; Choi H; Park SG; Park WJ; Kim DH; Park ZY
    Mol Cells; 2021 Jul; 44(7):500-516. PubMed ID: 34158421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ascending aortic constriction in rats for creation of pressure overload cardiac hypertrophy model.
    Gs AK; Raj B; Santhosh KS; Sanjay G; Kartha CC
    J Vis Exp; 2014 Jun; (88):e50983. PubMed ID: 24998889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA damage and nuclear morphological changes in cardiac hypertrophy are mediated by SNRK through actin depolymerization.
    Stanczyk P; Tatekoshi Y; Shapiro JS; Nayudu K; Chen Y; Zilber Z; Schipma M; De Jesus A; Mahmoodzadeh A; Akrami A; Chang HC; Ardehali H
    bioRxiv; 2023 Jul; ():. PubMed ID: 37503243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental modelling of cardiac pressure overload hypertrophy: Modified technique for precise, reproducible, safe and easy aortic arch banding-debanding in mice.
    Merino D; Gil A; Gómez J; Ruiz L; Llano M; García R; Hurlé MA; Nistal JF
    Sci Rep; 2018 Feb; 8(1):3167. PubMed ID: 29453394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UGCG modulates heart hypertrophy through B4GalT5-mediated mitochondrial oxidative stress and the ERK signaling pathway.
    Cui S; Zhang X; Li Y; Hu S; Wu B; Fang Z; Gao J; Li M; Wu H; Tao B; Xia H; Xu L
    Cell Mol Biol Lett; 2023 Sep; 28(1):71. PubMed ID: 37658291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three TF Co-expression Modules Regulate Pressure-Overload Cardiac Hypertrophy in Male Mice.
    Chang YM; Ling L; Chang YT; Chang YW; Li WH; Shih AC; Chen CC
    Sci Rep; 2017 Aug; 7(1):7560. PubMed ID: 28790436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multiscale model of cardiac concentric hypertrophy incorporating both mechanical and hormonal drivers of growth.
    Estrada AC; Yoshida K; Saucerman JJ; Holmes JW
    Biomech Model Mechanobiol; 2021 Feb; 20(1):293-307. PubMed ID: 32970240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD9 exacerbates pathological cardiac hypertrophy through regulating GP130/STAT3 signaling pathway.
    Li Y; Fan S; Kong L; Hao Z; Zhou Y; Shangguan J; Gao L; Wang M; Kang Y; Li X; Huang K; Zhang C; Liu Z
    iScience; 2023 Nov; 26(11):108070. PubMed ID: 37860696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.